Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,315 INR | +2.43% | -1.61% | +18.07% |
03-29 | Ipca Laboratories Limited Announces Cessation of Anand T. Kusre as an Independent Director | CI |
03-29 | Ipca Laboratories Limited Appoints Swati Arvind Patankar as an Independent Director | CI |
Chart calendar Ipca Laboratories Limited
Upcoming events on Ipca Laboratories Limited
Past events on Ipca Laboratories Limited
15/02/2024 10:00 | Q3 2024 Earnings Call |
14/02/2024 08:12 | Q3 2024 Earnings Release |
21/11/2023 | Ex-dividend day for dividende intermédiaire |
10/11/2023 10:30 | Q2 2024 Earnings Call |
10/11/2023 08:09 | Q2 2024 Earnings Release |
10/08/2023 11:00 | Annual General Meeting |
10/08/2023 08:38 | Q1 2024 Earnings Release |
29/05/2023 09:10 | Q4 2023 Earnings Release |
25/04/2023 11:30 | Acquisition of Unichem Laboratories Limited by Ipca Laboratories Limited Call |
16/02/2023 10:30 | Q3 2023 Earnings Call |
14/02/2023 07:39 | Q3 2023 Earnings Release |
14/11/2022 11:30 | Interim 2023 Earnings Call |
11/11/2022 07:54 | Interim 2023 Earnings Release |
05/08/2019 | Ex-dividend day for final dividend |
30/05/2019 11:00 | FY 2019 Earnings Call |
28/05/2019 | FY 2019 Earnings Release |
13/02/2019 05:30 | Q3 2019 Earnings Call |
11/02/2019 | Q3 2019 Earnings Release |
15/11/2018 05:30 | Interim 2019 Earnings Call |
13/11/2018 | Interim 2019 Earnings Release |
Past dividends on Ipca Laboratories Limited
21/11/2023 | Interim Payment 2 INR |
21/11/2022 | Interim Payment 4 INR |
21/11/2021 | Interim Payment 8 INR |
12/11/2020 | Interim Payment 8 INR |
17/02/2020 | Interim Payment 5 INR |
05/08/2019 | Annual 3 INR |
01/08/2018 | Annual 1 INR |
26/07/2017 | Annual 1 INR |
21/07/2015 | Annual 1 INR |
17/07/2014 | Final Payment 2.5 INR |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 37 732 37 160 1.54% | 46 487 45 629 1.88% | 54 200 55 364 -2.1% | 58 298 58 316 -0.03% | 62 443 61 951 0.79% | 75 749 |
EBITDA Million INR | Released Forecast Spread | 6 901 6 893 0.11% | 9 067 9 595 -5.5% | 15 444 15 977 -3.34% | 13 073 13 506 -3.21% | 9 268 10 339 -10.36% | 12 951 |
EBIT Million INR | Released Forecast Spread | 5 077 5 092 -0.31% | 6 962 7 829 -11.07% | 13 352 14 040 -4.9% | 10 748 11 107 -3.23% | 6 652 8 017 -17.02% | 9 768 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 5 465 5 373 1.71% | 7 367 8 107 -9.13% | 13 813 14 536 -4.98% | 11 357 11 680 -2.76% | 7 453 8 218 -9.31% | 9 496 |
Net income Million INR | Released Forecast Spread | 4 422 4 406 0.37% | 6 036 6 690 -9.79% | 11 400 11 831 -3.64% | 8 841 9 300 -4.93% | 4 713 5 488 -14.12% | 6 318 |
EPS INR | Released Forecast Spread | 17,5 17,1 2.36% | 23,9 26,3 -9.38% | 45,1 47,0 -4.05% | 34,9 37,3 -6.57% | 18,6 23,2 -20% | 24,7 |
Announcement Date | 29/05/19 | 16/06/20 | 28/05/21 | 24/05/22 | 29/05/23 | - |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 11 147 12 841 -13.2% | 15 658 13 794 13.51% | 15 444 15 195 1.64% | 14 305 14 502 -1.36% | 12 891 13 039 -1.14% | 15 857 14 667 8.12% | 16 010 16 670 -3.96% | 15 460 15 358 0.66% | 15 116 14 448 4.62% | 15 876 16 678 -4.81% | 17 241 | 20 834 | 20 430 |
EBITDA Million INR | Released Forecast Spread | 2 289 3 020 -24.2% | 4 165 3 524 18.2% | 3 656 3 959 -7.67% | 3 078 3 218 -4.35% | 2 193 2 490 -11.93% | 2 692 3 138 -14.22% | 2 606 3 346 -22.09% | 2 159 2 716 -20.53% | 1 810 2 088 -13.3% | 3 076 2 735 12.47% | 3 381 | 3 433 | 3 189 |
EBIT Million INR | Released Forecast Spread | 1 764 2 659 -33.66% | 3 607 2 895 24.58% | 3 086 3 422 -9.81% | 2 491 2 908 -14.34% | 1 584 1 902 -16.7% | 2 075 2 569 -19.22% | 1 969 2 949 -33.22% | 1 493 2 276 -34.39% | 1 115 1 548 -27.95% | 2 384 2 575 -7.44% | 2 791 | 2 377 | 1 904 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 921 2 726 -29.52% | 3 774 3 059 23.39% | 3 256 3 587 -9.22% | 2 607 2 690 -3.1% | 1 696 1 997 -15.1% | 2 227 2 427 -8.23% | 2 238 2 951 -24.16% | 1 693 2 232 -24.11% | 1 294 1 536 -15.7% | 2 518 2 334 7.88% | 2 699 | 2 369 | 1 844 |
Net income Million INR | Released Forecast Spread | 1 613 2 170 -25.64% | 3 067 2 546 20.43% | 2 502 2 882 -13.17% | 1 970 2 291 -14.02% | 1 302 1 644 -20.79% | 1 431 1 981 -27.77% | 1 439 2 157 -33.29% | 1 078 1 641 -34.26% | 765 1 187 -35.54% | 1 628 1 572 3.55% | 1 911 | 1 667 | 1 294 |
EPS INR | Released Forecast Spread | 6,36 8,35 -23.89% | 12,1 9,68 24.96% | 9,87 11,0 -10.11% | 7,76 9,80 -20.82% | 5,13 7,25 -29.24% | 5,64 8,10 -30.37% | 5,67 6,90 -17.83% | 4,25 6,30 -32.54% | 3,02 4,90 -38.37% | 6,42 4,80 33.75% | 7,10 | 5,68 | |
Announcement Date | 28/05/21 | 05/08/21 | 13/11/21 | 14/02/22 | 24/05/22 | 10/08/22 | 11/11/22 | 14/02/23 | 29/05/23 | 10/08/23 | - | - | - |
Past sector events for Ipca Laboratories Limited
10/05/2024 16:01 | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
10/05/2024 11:50 | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
10/05/2024 11:46 | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
09/05/2024 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
09/05/2024 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
09/05/2024 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
09/05/2024 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
09/05/2024 21:02 | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
09/05/2024 14:58 | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
09/05/2024 14:06 | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IPCALAB Stock
- IPCALAB Stock
- Calendar Ipca Laboratories Limited